🇺🇸 FDA

Intelligence · Clinical Pipeline

Jazz Pharmaceuticals Ireland Pipeline

All ClinicalTrials.gov programs at Jazz Pharmaceuticals Ireland — phase, modality, and trial IDs.

Programs
208

Quick answer

Jazz Pharmaceuticals Ireland has 208 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Fludarabine

    Jazz Pharmaceuticals Ireland Limited

    Hematologic Malignancy

    phase 2 small molecule terminated

    1 trial

  2. GWP42003

    Jazz Pharmaceuticals Ireland Limited

    Dyslipidemias

    phase 2 small molecule completed

    1 trial

  3. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Schizophrenia

    phase 2 small molecule terminated

    1 trial

  4. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Autism Spectrum Disorder

    phase 2 small molecule completed

    1 trial

  5. GWP42003-P 5 mg/kg/day Dose

    Jazz Pharmaceuticals Ireland Limited

    Epilepsy

    phase 2 small molecule completed

    1 trial

  6. GWP42004

    Jazz Pharmaceuticals Ireland Limited

    Diabetes Mellitus, Type 2

    phase 2 small molecule completed

    1 trial

  7. GWP42006

    Jazz Pharmaceuticals Ireland Limited

    Autism Spectrum Disorder

    phase 2 small molecule terminated

    1 trial

  8. GWP42006

    Jazz Pharmaceuticals Ireland Limited

    Epilepsy

    phase 2 small molecule completed

    2 trials

  9. Glasdegib

    Jazz Pharmaceuticals Ireland Limited

    Acute Myelogenous Leukemia (AML) Due to Therapy

    phase 2 small molecule active

    1 trial

  10. IBRANCE 125 mg hard capsules, IBRANCE 125 mg hard capsules, IBRANCE 125 mg hard capsules, Faslodex 250 mg solution for injection., JZP598

    Jazz Pharmaceuticals Ireland Limited

    Breast cancer patients including those with locally advanced (unresectable) or metastatic HER2-positive, HR-positive breast cancer

    phase 2 small molecule active

    1 trial

  11. JZP-110

    Jazz Pharmaceuticals Ireland Limited

    Excessive Sleepiness

    phase 2 small molecule completed

    1 trial

  12. JZP150

    Jazz Pharmaceuticals Ireland Limited

    Post Traumatic Stress Disorder

    phase 2 small molecule completed

    1 trial

  13. JZP3507

    Jazz Pharmaceuticals Ireland Limited

    Meningioma

    phase 2 small molecule active

    1 trial

  14. JZP385

    Jazz Pharmaceuticals Ireland Limited

    Essential Tremor

    phase 2 small molecule completed

    1 trial

  15. JZP541

    Jazz Pharmaceuticals Ireland Limited

    Irritability Associated With Autism Spectrum Disorder

    phase 2 small molecule terminated

    1 trial

  16. JZP598

    Jazz Pharmaceuticals Ireland Limited

    Patients with HER2-expressing solid tumors

    phase 2 small molecule active

    1 trial

  17. JZP598, TRASTUZUMAB EMTANSINE, DOCETAXEL , TRASTUZUMAB , PACLITAXEL , PACLITAXEL ALBUMIN-BOUND, PERTUZUMAB , CARBOPLATIN , TRASTUZUMAB EMTANSINE

    Jazz Pharmaceuticals Ireland Limited

    HER2-positive breast cancer

    phase 2 small molecule active

    1 trial

  18. Liposome-encapsulated Daunorubicin-Cytarabine

    Jazz Pharmaceuticals Ireland Limited

    Essential Thrombocythemia

    phase 2 small molecule terminated

    1 trial

  19. Liposome-encapsulated Daunorubicin-Cytarabine

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia

    phase 2 small molecule active

    2 trials

  20. Liposome-encapsulated Daunorubicin-Cytarabine

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    phase 2 small molecule active

    1 trial

  21. Lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Ewing Sarcoma

    phase 2 small molecule active

    1 trial

  22. Lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Advanced Soft-tissue Sarcoma

    phase 2 small molecule active

    1 trial

  23. Lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Small Cell Lung Cancer ( SCLC )

    phase 2 small molecule active

    1 trial

  24. Lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Refractory Ewing Sarcoma

    phase 2 small molecule active

    1 trial

  25. Lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Locally Advanced Soft Tissue Sarcoma

    phase 2 small molecule terminated

    1 trial

  26. Lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Advanced Solid Tumor

    phase 2 small molecule terminated

    1 trial

  27. Lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Extensive-stage Small-cell Lung Cancer

    phase 2 small molecule active

    1 trial

  28. Lurbinectedin 4 MG Injection [Zepzelca]

    Jazz Pharmaceuticals Ireland Limited

    Gastrointestinal Malignancies

    phase 2 small molecule completed

    1 trial

  29. Nabiximols

    Jazz Pharmaceuticals Ireland Limited

    NMO Spectrum Disorder

    phase 2 small molecule terminated

    1 trial

  30. Nabiximols

    Jazz Pharmaceuticals Ireland Limited

    Glioblastoma

    phase 2 small molecule active

    1 trial

  31. ONC201

    Jazz Pharmaceuticals Ireland Limited

    Advanced Glioblastoma

    phase 2 small molecule terminated

    1 trial

  32. ONC201

    Jazz Pharmaceuticals Ireland Limited

    Diffuse Intrinsic Pontine Glioma

    phase 2 small molecule active

    1 trial

  33. ONC201

    Jazz Pharmaceuticals Ireland Limited

    Meningioma

    phase 2 small molecule terminated

    1 trial

  34. ONC201

    Jazz Pharmaceuticals Ireland Limited

    Multiple Myeloma

    phase 2 small molecule terminated

    1 trial

  35. ONC206

    Jazz Pharmaceuticals Ireland Limited

    Advanced Pheochromocytoma and Paraganglioma

    phase 2 small molecule active

    1 trial

  36. Open-Label

    Jazz Pharmaceuticals Ireland Limited

    Chronic Obstructive Pulmonary Disease

    phase 2 small molecule terminated

    1 trial

  37. Paclitaxel

    Jazz Pharmaceuticals Ireland Limited

    Gastroesophageal Adenocarcinoma

    phase 2 small molecule active

    1 trial

  38. Placebo

    Jazz Pharmaceuticals Ireland Limited

    Parkinson Disease

    phase 2 small molecule completed

    1 trial

  39. Placebo

    Jazz Pharmaceuticals Ireland Limited

    Schizophrenia

    phase 2 small molecule completed

    1 trial

  40. Placebo

    Jazz Pharmaceuticals Ireland Limited

    Viruria

    phase 2 small molecule completed

    1 trial

  41. Sativex

    Jazz Pharmaceuticals Ireland Limited

    Cancer

    phase 2 small molecule completed

    2 trials

  42. Sm-EDTMP

    Jazz Pharmaceuticals Ireland Limited

    Metastatic Osteosarcoma

    phase 2 small molecule terminated

    1 trial

  43. Sodium Oxybate

    Jazz Pharmaceuticals Ireland Limited

    Essential Tremor

    phase 2 small molecule completed

    1 trial

  44. Sodium Oxybate

    Jazz Pharmaceuticals Ireland Limited

    Alternating Hemiplegia of Childhood

    phase 2 small molecule completed

    1 trial

  45. Sodium Oxybate

    Jazz Pharmaceuticals Ireland Limited

    Schizophrenia

    phase 2 small molecule completed

    1 trial

  46. Xyrem (sodium oxybate) oral solution

    Jazz Pharmaceuticals Ireland Limited

    Fibromyalgia

    phase 2 small molecule completed

    1 trial

  47. ZW25 (Zanidatamab)

    Jazz Pharmaceuticals Ireland Limited

    HER2+/HR+ Breast Cancer

    phase 2 small molecule completed

    1 trial

  48. ZW25 (Zanidatamab)

    Jazz Pharmaceuticals Ireland Limited

    HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Jazz Pharmaceuticals Ireland have?

208 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.